Table of Contents

Executive Summary

1 Celiac Drugs Market Overview

• 1.1 Product Overview and Scope of Celiac Drugs
• 1.2 Celiac Drugs Segment by Type
  • 1.2.1 Global Celiac Drugs Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 First Line Of Treatment
  • 1.2.3 Second Line Of Treatment
• 1.3 Celiac Drugs Segment by Application
  • 1.3.1 Celiac Drugs Consumption Comparison by Application (2014-2025)
  • 1.3.2 Men
  • 1.3.3 Women
  • 1.3.4 Children
• 1.4 Global Celiac Drugs Market by Region
  • 1.4.1 Global Celiac Drugs Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Celiac Drugs Market Size
  • 1.5.1 Global Celiac Drugs Revenue (2014-2025)
  • 1.5.2 Global Celiac Drugs Production (2014-2025)

2 Global Celiac Drugs Market Competition by Manufacturers

• 2.1 Global Celiac Drugs Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Celiac Drugs Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Celiac Drugs Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Celiac Drugs Production Sites, Area Served, Product Types
• 2.5 Celiac Drugs Market Competitive Situation and Trends
  • 2.5.1 Celiac Drugs Market Concentration Rate
  • 2.5.2 Celiac Drugs Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Celiac Drugs Production Market Share by Regions

• 3.1 Global Celiac Drugs Production Market Share by Regions
• 3.2 Global Celiac Drugs Revenue Market Share by Regions (2014-2019)
• 3.3 Global Celiac Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Celiac Drugs Production
  • 3.4.1 North America Celiac Drugs Production Growth Rate (2014-2019)
  • 3.4.2 North America Celiac Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Celiac Drugs Production
  • 3.5.1 Europe Celiac Drugs Production Growth Rate (2014-2019)
  • 3.5.2 Europe Celiac Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Celiac Drugs Production (2014-2019)
  • 3.6.1 China Celiac Drugs Production Growth Rate (2014-2019)
  • 3.6.2 China Celiac Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Celiac Drugs Production (2014-2019)
  • 3.7.1 Japan Celiac Drugs Production Growth Rate (2014-2019)
  • 3.7.2 Japan Celiac Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Celiac Drugs Consumption by Regions

• 4.1 Global Celiac Drugs Consumption by Regions
• 4.2 North America Celiac Drugs Consumption (2014-2019)
• 4.3 Europe Celiac Drugs Consumption (2014-2019)
• 4.4 China Celiac Drugs Consumption (2014-2019)
• 4.5 Japan Celiac Drugs Consumption (2014-2019)

5 Global Celiac Drugs Production, Revenue, Price Trend by Type

• 5.1 Global Celiac Drugs Production Market Share by Type (2014-2019)
• 5.2 Global Celiac Drugs Revenue Market Share by Type (2014-2019)
• 5.3 Global Celiac Drugs Price by Type (2014-2019)
• 5.4 Global Celiac Drugs Production Growth by Type (2014-2019)

6 Global Celiac Drugs Market Analysis by Applications

• 6.1 Global Celiac Drugs Consumption Market Share by Application (2014-2019)
• 6.2 Global Celiac Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Celiac Drugs Business

• 7.1 ADMA Biologics
  • 7.1.1 ADMA Biologics Celiac Drugs Production Sites and Area Served
  • 7.1.2 Celiac Drugs Product Introduction, Application and Specification
  • 7.1.3 ADMA Biologics Celiac Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Amgen
  • 7.2.1 Amgen Celiac Drugs Production Sites and Area Served
  • 7.2.2 Celiac Drugs Product Introduction, Application and Specification
  • 7.2.3 Amgen Celiac Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Anthera Pharmaceuticals
  • 7.3.1 Anthera Pharmaceuticals Celiac Drugs Production Sites and Area Served
  • 7.3.2 Celiac Drugs Product Introduction, Application and Specification
  • 7.3.3 Anthera Pharmaceuticals Celiac Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Bayer
  • 7.4.1 Bayer Celiac Drugs Production Sites and Area Served
  • 7.4.2 Celiac Drugs Product Introduction, Application and Specification
  • 7.4.3 Bayer Celiac Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Biogen
  • 7.5.1 Biogen Celiac Drugs Production Sites and Area Served
  • 7.5.2 Celiac Drugs Product Introduction, Application and Specification
  • 7.5.3 Biogen Celiac Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 BioLineRx
  • 7.6.1 BioLineRx Celiac Drugs Production Sites and Area Served
  • 7.6.2 Celiac Drugs Product Introduction, Application and Specification
  • 7.6.3 BioLineRx Celiac Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Biotest
  • 7.7.1 Biotest Celiac Drugs Production Sites and Area Served
  • 7.7.2 Celiac Drugs Product Introduction, Application and Specification
  • 7.7.3 Biotest Celiac Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Bristol-Myers Squibb
  • 7.8.1 Bristol-Myers Squibb Celiac Drugs Production Sites and Area Served
  • 7.8.2 Celiac Drugs Product Introduction, Application and Specification
  • 7.8.3 Bristol-Myers Squibb Celiac Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Celgene
  • 7.9.1 Celgene Celiac Drugs Production Sites and Area Served
  • 7.9.2 Celiac Drugs Product Introduction, Application and Specification
  • 7.9.3 Celgene Celiac Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Celimmune
  • 7.10.1 Celimmune Celiac Drugs Production Sites and Area Served
  • 7.10.2 Celiac Drugs Product Introduction, Application and Specification
  • 7.10.3 Celimmune Celiac Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 F Hoffmann-La Roche
• 7.12 ImmunogenX
• 7.13 Immunomedics
• 7.14 ImmusanT
• 7.15 Innovate Biopharmaceuticals
• 7.16 Johnson & Johnson
• 7.17 Kedrion Biopharma
• 7.18 LFB Group
• 7.19 Merck
• 7.20 Novartis

8 Celiac Drugs Manufacturing Cost Analysis

• 8.1 Celiac Drugs Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Celiac Drugs
• 8.4 Celiac Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Celiac Drugs Distributors List
• 9.3 Celiac Drugs Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Celiac Drugs Market Forecast

• 11.1 Global Celiac Drugs Production, Revenue Forecast
  • 11.1.1 Global Celiac Drugs Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Celiac Drugs Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Celiac Drugs Price and Trend Forecast (2019-2025)
• 11.2 Global Celiac Drugs Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Celiac Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Celiac Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Celiac Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Celiac Drugs Production, Revenue Forecast (2019-2025)
• 11.3 Global Celiac Drugs Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Celiac Drugs Consumption Forecast (2019-2025)
  • 11.3.2 Europe Celiac Drugs Consumption Forecast (2019-2025)
  • 11.3.3 China Celiac Drugs Consumption Forecast (2019-2025)
  • 11.3.4 Japan Celiac Drugs Consumption Forecast (2019-2025)
• 11.4 Global Celiac Drugs Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Celiac Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

Celiac disease, also known as celiac sprue or gluten-sensitive enteropathy, is a genetic autoimmune disorder caused due to the body’s inability to process gluten that causes damage to the small intestine. Gluten, a protein found in wheat, barley, and rye, can damage the lining of the small intestine which makes it difficult for the body to absorb nutrients such as iron, fat, calcium, and folate. The immune system mistakes substances inside gluten to be a threat to the body and attacks them, in turn, causing damage to the bowel surface and hampering the body’s ability to absorb nutrition. Digestion problems, dermatitis herpetiformis, abdominal pain, weight loss, musculoskeletal problems, aphthous ulcers, iron deficiency, stunted growth, tingling sensation in the leg, and missed menstrual cycles are some of the symptoms of celiac disease. The disease can lead to various complications and health problems such as miscarriage or infertility, intestinal cancer, osteoporosis, seizures, gall bladder malfunction, neurological manifestation of the disease, stunted growth in children, and birth defects. Celiac disease can also lead to various autoimmune diseases such as lupus, thyroid disease, Sjögren's syndrome, type 1 diabetes, and rheumatoid arthritis. It is difficult to diagnose celiac disease in the initial stages as its symptoms are similar to those of other diseases. Various sensitive and selective blood tests such as anti-tissue transglutaminase antibodies with or without IgA level and IgA anti-endomysial antibodies are used to screen the disease. 
North America dominates the global market for celiac drugs due to rising incidence of celiac disease and lack of treatment options in the region. Asia is expected to show high growth rates in the next five years in global celiac drugs market, with China and India being the fastest growing markets in the Asia-Pacific region. The key driving forces for the celiac drugs market in developing countries are the large pool of patients, increasing awareness about the disease, and rising government funding in the region. 

The global Celiac Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Celiac Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Celiac Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Celimmune
F Hoffmann-La Roche
ImmunogenX
Immunomedics
ImmusanT
Innovate Biopharmaceuticals
Johnson & Johnson
Kedrion Biopharma
LFB Group
Merck
Novartis

Segment by Regions
North America
Europe
China
Japan

Segment by Type
First Line Of Treatment
Second Line Of Treatment

Segment by Application
Men
Women
Children